Email: zheny1379@163.com

Education Background: 
2019-2025, Ph.D., Pharmacy, East China University Of Science And Technology. 
2015-2019, B.E., Pharmaceutical Preparations, Jiujiang University.

Introduction:  
I was born in Jiangxi, China, and obtained my bachelor's degree from Jiujiang University in 2019. I am currently a Ph.D. candidate in the research group of Professor Li at East China University of Science and Technology, specializing in computer-aided drug design.

Publication:

1. Jiawen Wang^†; Zhen Yuan^†; Na Yu, Qian Jiao, Honglei Zhou, Wenjie Liao, Jiwei Shan, Shanshan Ruan, Yi Zhao, Ya Mo, Luyao Qi, Tiejun Li, Jianjun Fu, Bowen Ke, Yufang Xu, Xuhong Qian, Jian Zhang, Zhenjiang Zhao, Shiliang Li*, Rui Wang*, Honglin Li*. Inactivation of RhoA for Hypertension Treatment Through the TRPV4-RhoA-RhoGDI1 Axis. Circulation.2025

2. Zhen Yuan^†, Xingyu Chen^†, Sisi Fan, Longfeng Chang, Linna Chu, Ying Zhang, Jie Wang, Shuang Li, Jinxin Xie, Jianguo Hu, Runyu Miao, Lili Zhu, Zhenjiang Zhao, Honglin Li*, Shiliang Li*. Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors. Int. J. Mol. Sci., 2024. 25(1): 671

3. Zhen Yuan^†, Manzhan Zhang^†, Longfeng Chang^†, Xingyu Chen, Shanshan Ruan, Shanshan Shi, Yiqing Zhang, Lili Zhu*, Honglin Li*, Shiliang Li*. Discovery of a novel SHP2 allosteric inhibitor using virtual screening, FMO calculation, and molecular dynamic simulation. J. Mol. Model., 2024. 30(5), 131 

4. Che Qiu^†, Zhen Yuan^†, Zhiyan He, Huiwen Chen, Yue Liao, Shiliang Li, Wei Zhou*, Zhongchen Song*. Lipopolysaccharide Preparation Derived from Porphyromonas gingivalis Induces a Weaker Immuno-Inflammatory Response in BV-2 Microglial Cells Than Escherichia coli by Differentially Activating TLR2/4-Mediated NF-kB/STAT3 Signaling Pathways. Front. Cell. Infect. Microbiol., 2021. 11: 606986